Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.0%

1 terminated out of 25 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

89% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (12)
P 2 (4)
P 3 (2)

Trial Status

Recruiting9
Completed8
Unknown5
Not Yet Recruiting2
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07398209Not ApplicableNot Yet Recruiting

GCC 2546- Motion Management

NCT06295783RecruitingPrimary

Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect

NCT04069884Not ApplicableRecruiting

RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer

NCT07162714Phase 2Not Yet Recruiting

SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer

NCT07043790Not ApplicableCompleted

Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

NCT06214611Not ApplicableRecruiting

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors

NCT06253338Not ApplicableRecruiting

Optimization of Radiation Protection Through Genomic Analyses

NCT06514118Recruiting

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

NCT01284153Recruiting

Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study

NCT06230549Not ApplicableRecruiting

Adaptive Radiotherapy in Patients With Gynecological Tumors

NCT05669092Phase 3Unknown

A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status

NCT04967976Not ApplicableRecruiting

Breast Mesh Used in Two-staged Breast Reconstruction

NCT03484221Phase 2Unknown

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

NCT04814069Phase 2Unknown

A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma:The POTENTIAL Study

NCT03920033Not ApplicableRecruiting

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy

NCT03461341Completed

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

NCT03735706Not ApplicableCompletedPrimary

Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight.

NCT03235427Completed

The CAROLE (CArdiac Related Oncologic Late Effects) Study

NCT02188563Not ApplicableCompleted

A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers

NCT03259126Not ApplicableCompletedPrimary

EXTended pRotective Curtain Under Table to Reduce Operator RAdiation Dose in Percutaneous Coronary Procedures

Scroll to load more

Research Network

Activity Timeline